Zobrazeno 1 - 10
of 11 221
pro vyhledávání: '"long-covid"'
Autor:
Friedman, Kenneth J., author, Ruhoy, Ilene S., author, Fennell, Patricia A., author, George, Shane, author
Publikováno v:
Infectious Diseases in Neurocognitive and Neuropsychiatric Medicine, 2024.
Externí odkaz:
https://doi.org/10.1093/oso/9780192870414.003.0023
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-13 (2024)
Abstract Background To evaluate the impact of coronavirus disease 2019 (COVID-19) on polysomnographic evaluation in patients with Prader-Willi syndrome (PWS). Patients and methods A retrospective cohort study of two consecutive overnight polysomnogra
Externí odkaz:
https://doaj.org/article/8a7d671a968c43dcbeb132e435c9dbd4
Autor:
Wolfram Doehner, Azadeh Fischer, Banafsheh Alimi, Jasmin Muhar, Jochen Springer, Christoph Altmann, Per Otto Schueller
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 6, Pp 2781-2791 (2024)
ABSTRACT Introduction Long COVID‐19 illness is a severely disabling disease with shortness of breath, weakness and fatigue as leading symptoms, resulting in poor quality of life and substantial delay in return to work. No specific respiratory thera
Externí odkaz:
https://doaj.org/article/3c5b4927eb05425dbeb21b8a71ec46fd
Autor:
McNaughton CD, Austin PC, Li Z, Sivaswamy A, Fang J, Abdel-Qadir H, Udell JA, Wodchis WP, Lee DS, Mostarac I, Atzema CL
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol Volume 17, Pp 5749-5761 (2024)
Candace D McNaughton,1– 4 Peter C Austin,1,2,4 Zhiyin Li,1 Atul Sivaswamy,1 Jiming Fang,1 Husam Abdel-Qadir,1,3– 5 Jacob A Udell,1,5 Walter P Wodchis,1,4,6 Douglas S Lee,1,3,4,7 Ivona Mostarac,2 Clare L Atzema1– 4 1ICES (Formerly, the Institute
Externí odkaz:
https://doaj.org/article/259e4caaebec464f8edfbbf57eec2101
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study explores the health-related quality of life (HRQoL) experienced by patients with Long COVD-19 using data from British Columbia’s post-COVID-19 Recovery Clinics. A retrospective cohort of 3463 patients was analyzed to assess HRQo
Externí odkaz:
https://doaj.org/article/a9306436f52e41778a2a2a280e36bb5f
Autor:
Maaike Cockx, Nick Geukens, Birthe Michiels, Doreen Dillaerts, Eveline Claeys, Olivia Vandekerckhove, Natalie Lorent, Xavier Bossuyt
Publikováno v:
Clinical Immunology Communications, Vol 6, Iss , Pp 26-30 (2024)
Anti-type-I interferon (IFN) autoantibodies have been associated with severe COVID-19. Their association with long COVID, however, is unclear.Anti-IFN-α2 antibody levels were followed-up for one year in individuals hospitalized for acute COVID-19 (n
Externí odkaz:
https://doaj.org/article/29b864d535f841729c7fde3f08dde7f0
Autor:
Tejas Menon Suri, Garima Srivastava, Sunil Kumar, A Surendranath, Syam Shaji, Saurabh Mittal, Pawan Tiwari, Vijay Hadda, Karan Madan, Abhishek Chauhan, Anant Mohan
Publikováno v:
Lung India, Vol 41, Iss 6, Pp 405-410 (2024)
Background Persistent dyspnoea and pulmonary function impairment are common after coronavirus disease 2019 (COVID-19). However, long-term outcomes beyond 2 years of infection are unknown. Methods In this single-center study, we observed the trend of
Externí odkaz:
https://doaj.org/article/45a0b3aafa50449cb20c0397d732b2d2
Autor:
Medha Deepak Bargaje, Priyasha Sharma, Jyoti Deepak Londhe, Sanjeevani Vishwanath Patil, Anita Tulsiramji Anokar, Purwa Prakash Doke, Jitendra Shankarlal Oswal, Prakash Prabhakarrao Doke, Kranti Laxman Rayamane, Nachiket Sandeep Sule, Aruna Bhimsen Deshpande
Publikováno v:
Lung India, Vol 41, Iss 6, Pp 435-441 (2024)
Background The need of pulmonary rehabilitation (PR) for COVID-19 patients with long-term effects was desperately felt. The study’s objective was to measure the effect of PR on functional capacity and health-related quality of life (HRQOL) in patie
Externí odkaz:
https://doaj.org/article/defdb1a6baf0416c805c1530e9a1a7c5
Autor:
Hythem Sidky, Kristen A. Hansen, Andrew T. Girvin, Nathan Hotaling, Sam G. Michael, Ken Gersing, David K. Sahner
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 24, Iss , Pp 115-125 (2024)
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their central,
Externí odkaz:
https://doaj.org/article/c0703b56ad684394a97e3a2666d7049f
Autor:
Ermanno Cordelli, Paolo Soda, Sara Citter, Elia Schiavon, Christian Salvatore, Deborah Fazzini, Greta Clementi, Michaela Cellina, Andrea Cozzi, Chandra Bortolotto, Lorenzo Preda, Luisa Francini, Matteo Tortora, Isabella Castiglioni, Sergio Papa, Diego Sona, Marco Alì
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Long COVID is a multi-systemic disease characterized by the persistence or occurrence of many symptoms that in many cases affect the pulmonary system. These, in turn, may deteriorate the patient’s quality of life making it easier to develo
Externí odkaz:
https://doaj.org/article/c54e384d5fe54c018bf82f03f3251613